Brain-to-Society Diagnostic for Prevention of Childhood Obesity and Chronic Disease
NCT ID: NCT03151694
Last Updated: 2017-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1224 participants
OBSERVATIONAL
2011-02-01
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Child Care-based Obesity Prevention Intervention
NCT01679938
Evaluation of the Impact of Eating Habits on Children's Corpulence
NCT06128083
Paediatric Obesity and Cardiovascular Dysfunction
NCT03169257
Study of Technology to Accelerate Research
NCT01537510
Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity
NCT05700409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DRD4 and DRD2 Polymorphism Detection
The genetic component of endophenotype for responsiveness to environment (ERE) will be characterized with reference to Taq1A allele in dopamine-2 receptor (DRD2) gene and the exon 3 7-repeat allele of the dopamine-4 receptor (DRD4) gene. This will assist in understanding the role of DRD2 and DRD4 in shaping the neurocognitive functions and link to the eating behaviors of the children and other primary outcome variables.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The INCLEN Trust International
UNKNOWN
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurette Dubé, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
McGill University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill Centre for the Convergence of Health and Economics (MCCHE)
Montreal, Quebec, Canada
The INCLEN Trust International
New Delhi, , India
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Peer-Reviewed Article
View DocumentDocument Type: Peer-Reviewed Article
View DocumentDocument Type: Peer-Reviewed Article
View DocumentOther Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
227856
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.